SL Swiss Lipid Navigator
Demonstration prototype — synthetic data only, simplified rules, not for clinical use.
Step 10 of 10 · Decision support

Summary

What this step shows

All results for this patient in one view, with the reasoning behind each step. Update any value and the results are recalculated.

Muhammad Junaid
PT-0006 · 4 years · Male · born 01.02.2022 · LDL-C measured 03.09.2026
Update lab values
Clinical pathwaySpecial Category — Familial Hypercholesterolemia
Risk categoryHigh
LDL-C (current)0.6 mmol/L
LDL-C target<1.8 mmol/L
Current treatmentModerate-intensity statin (jj)
Recommended next stepAt target — continue current therapy and monitor
Swiss reimbursement Not applicable at this stage
Reasoning by step
  1. Step 5 — Clinical pathway View details →
    Special Category — Familial Hypercholesterolemia

    Patients with (suspected) FH are handled by dedicated FH risk rules rather than the general-population calculator.

  2. Step 6 — Cardiovascular risk View details →
    High

    Familial hypercholesterolemia with a very high LDL-C burden (or a high baseline plus an added risk factor) is treated as Very High risk in this demo ruleset.

  3. Step 7 — LDL-C target View details →
    <1.8 mmol/L

    High risk → target <1.8 mmol/L.

  4. Step 8 — Treatment plan View details →
    At target — continue current therapy and monitor

    LDL-C is already below target on the current regimen. No escalation needed; recommend routine monitoring.

  5. Step 9 — Swiss reimbursement View details →
    Not applicable at this stage

    This engine only activates once a PCSK9 inhibitor (or another reimbursement-restricted therapy) is clinically proposed. For this patient, the Treatment Engine recommended a different next step, so no reimbursement check is needed yet.

Demonstration output based on simplified rules — not clinical advice. Generated 02.11.2026 17:30.

← Swiss reimbursement
Back to patients →